BRPI0418335A - ácido nucléico codificando uma proteìna de receptor de postaglandina e métodos de uso desta - Google Patents

ácido nucléico codificando uma proteìna de receptor de postaglandina e métodos de uso desta

Info

Publication number
BRPI0418335A
BRPI0418335A BRPI0418335-5A BRPI0418335A BRPI0418335A BR PI0418335 A BRPI0418335 A BR PI0418335A BR PI0418335 A BRPI0418335 A BR PI0418335A BR PI0418335 A BRPI0418335 A BR PI0418335A
Authority
BR
Brazil
Prior art keywords
nucleic acid
methods
acid encoding
postaglandin
receptor protein
Prior art date
Application number
BRPI0418335-5A
Other languages
English (en)
Inventor
Paul August
Theresa Kuntzweiler
Ashfaq Parker
Mohamad Ali Ardati
Namadev Baskaran
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BRPI0418335A publication Critical patent/BRPI0418335A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CIDO NUCLéICO CODIFICANDO UMA PROTEìNA DE RECEPTOR DE PROSTAGLANDINA E MéTODOS DE USO DESTA. A presente invenção refere-se a um membro novo da família de receptor de prostanóide, um receptor de D2 de prostaglandina de porquinho-da-índia. Descritos são o receptor, o ácido nucléico que o codifica e vários usos para ambos.
BRPI0418335-5A 2003-12-30 2004-12-07 ácido nucléico codificando uma proteìna de receptor de postaglandina e métodos de uso desta BRPI0418335A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/747,994 US7183062B2 (en) 2003-12-30 2003-12-30 Prostaglandin receptor protein and methods of use thereof
PCT/US2004/040853 WO2005066209A1 (en) 2003-12-30 2004-12-07 Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0418335A true BRPI0418335A (pt) 2007-05-02

Family

ID=34700825

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418335-5A BRPI0418335A (pt) 2003-12-30 2004-12-07 ácido nucléico codificando uma proteìna de receptor de postaglandina e métodos de uso desta

Country Status (12)

Country Link
US (4) US7183062B2 (pt)
EP (1) EP1706422A1 (pt)
JP (1) JP4700620B2 (pt)
KR (1) KR20060105877A (pt)
CN (1) CN1898263B (pt)
AR (1) AR047356A1 (pt)
AU (1) AU2004312332B2 (pt)
BR (1) BRPI0418335A (pt)
CA (1) CA2551905C (pt)
IL (2) IL176445A0 (pt)
TW (1) TW200532019A (pt)
WO (1) WO2005066209A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133592A1 (en) * 1996-05-07 2003-07-17 Rhoads Geoffrey B. Content objects with computer instructions steganographically encoded therein, and associated methods
US7329725B1 (en) * 2003-10-29 2008-02-12 Nastech Pharmaceutical Company Inc. Phage displayed Trp cage ligands
US7704953B2 (en) * 2006-02-17 2010-04-27 Mdrna, Inc. Phage displayed cell binding peptides
CN111951887B (zh) * 2020-07-27 2024-06-28 深圳市新合生物医疗科技有限公司 基于深度学习的白细胞抗原与多肽结合亲和力预测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3671403B2 (ja) * 1994-03-22 2005-07-13 小野薬品工業株式会社 プロスタグランジンｄ受容体、その製造方法、その受容体をコードするｄｎａ、そのｄｎａからなるベクターおよびそのベクターで形質転換された宿主細胞
JP3064015B2 (ja) * 1995-01-26 2000-07-12 メルク フロスト カナダ アンド カンパニー プロスタグランジンレセプターｄｐ
CA2349815A1 (en) * 1998-11-12 2000-05-18 Incyte Pharmaceuticals, Inc. Human cell surface receptor proteins

Also Published As

Publication number Publication date
JP4700620B2 (ja) 2011-06-15
US20100152427A1 (en) 2010-06-17
CA2551905C (en) 2013-03-19
AR047356A1 (es) 2006-01-18
US20080020403A1 (en) 2008-01-24
KR20060105877A (ko) 2006-10-11
US20050142558A1 (en) 2005-06-30
CA2551905A1 (en) 2005-07-21
IL201026A0 (en) 2011-07-31
AU2004312332A1 (en) 2005-07-21
EP1706422A1 (en) 2006-10-04
TW200532019A (en) 2005-10-01
AU2004312332B2 (en) 2010-05-20
CN1898263A (zh) 2007-01-17
CN1898263B (zh) 2012-05-16
JP2008504010A (ja) 2008-02-14
US7723074B2 (en) 2010-05-25
US20090178151A1 (en) 2009-07-09
WO2005066209A1 (en) 2005-07-21
US7488799B2 (en) 2009-02-10
US7183062B2 (en) 2007-02-27
IL176445A0 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
CR10530A (es) Anticuerpos anti-dlla4 y metodos que los usan
HN2006016512A (es) Anticuerpos anti-il-6, composiciones, metodos y usos
CR20110245A (es) Mutantes fgf21 y uso de los mismos.
AR030760A1 (es) Nuevos acidos y polipeptidos nucleicos receptores
CR8257A (es) Construcciones de union y metodos para uso de ellas
CR11851A (es) Mutantes fgf21 y usos de los mismos
CR6538A (es) Anticuerpos de humano, anti-avb3 recombinantes, acidos nucleicos que codifican a los mismos y metodo de uso
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
DK1553975T3 (da) Optimerede Fc-varianter og fremgangsmåder til generering heraf.
BR122018016045B8 (pt) proteína variante otimizada
DK1409459T3 (da) ECL mærker, som har forbedrede, non-specifikke bindingsegenskaber, fremgangsmåder til anvendelse deraf, og kits indeholdende samme.
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
CY1112101T1 (el) Νευροτροφικοι παραγοντες
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
ECSP066559A (pt)
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
ECSP088743A (es) Anticuerpos para egfl7 y métodos para su uso
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
SE9801455D0 (sv) New receptor
BRPI0418335A (pt) ácido nucléico codificando uma proteìna de receptor de postaglandina e métodos de uso desta
MX9703364A (es) Peptidos capaces de unirse al dominio sh3 de la proteina gap, secuencias nucleotidicas que codifican para estos peptidos, su preparacion y su uso.
DK1446733T3 (da) Glycosylphosphatidylinositol indeholdende polypeptider
DE60219215D1 (de) Prionen-bindende peptidsequenzen

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: AVENTIS PHARMACEUTICALS, INC. (US)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070165509/RJ DE 23/11/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]